We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Deborah Siegal

Deborah Siegal MD, MSc, FRCPC

Associate Professor, Department of Medicine, Division of Hematology, University of Ottawa; Associate Scientist, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada

Dr. Deborah Siegal is an Associate Professor in the Department of Medicine within the Division of Hematology at the University of Ottawa.

Dr. Siegal graduated from Queen’s University School of Medicine in 2009 and completed Internal Medicine and Hematology training at McMaster University. She holds Master of Science degrees in Pharmacology (University of Toronto) and Health Research Methodology (McMaster University).

Dr. Siegal’s primary research interests include (i) improving patient outcomes after anticoagulant-related bleeding, (ii) management of anticoagulants in patients who have acute bleeding complications or require urgent surgery, (iii) understanding the factors that influence patient and physician decision-making after anticoagulant-related bleeding, and (iv) reducing red blood cell transfusion by minimizing iatrogenic blood loss for laboratory testing.

Dr. Siegal has expertise in the design and conduct of pragmatic cluster randomized trials, individual patient randomized trials, mixed-methods studies, observational studies and meta-analyses. She has received peer-reviewed grant support as principal investigator from the Canadian Institutes of Health Research, the American Society of Hematology, CanVECTOR/Heart and Stroke Foundation of Canada, Ontario AFP Innovation Fund, and Hamilton Health Sciences Foundation. She has published 80 peer-reviewed articles including several in high-impact journals such as The New England Journal of Medicine, Circulation, Blood, and Journal of Thrombosis and Haemostasis.

Disclosures

Dr. Deborah Siegal reports personal fees from Aspen Pharma, personal fees from Bayer, personal fees from BMS-Pfizer, personal fees from Leo Pharma, grants and personal fees from Novartis, personal fees from Portola, personal fees from Servier, outside the submitted work.